This trial is evaluating whether Stem Cell Educator therapy will improve 1 primary outcome and 4 secondary outcomes in patients with Diabetes Mellitus. Measurement will happen over the course of 6 month.
This trial requires 50 total participants across 2 different treatment groups
This trial involves 2 different treatments. Stem Cell Educator Therapy is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are in Phase 2 & 3 and have had some early promising results.
"Most diabetes related signs/symptoms are related to damage to the nervous system. Nerves such as the optic nerve and sensory nerves often show abnormalities on examination, and are more likely to suffer damage in diabetes. Some damage can be related to an autoimmune response. Autoimmune responses occur in many forms of diabetes, so it should be looked for systematically during diagnosis and follow up." - Anonymous Online Contributor
"As of early 2002, there were no controlled studies to identify criteria or treatment which were universally effective in halting or regressing some features of both type 1 and [type 2 diabetes](https://www.withpower.com/clinical-trials/type-2-diabetes). However, for type 1, even with good care, a persistent high blood sugar level can be the main cause of chronic kidney disease. There is no evidence that any of the drugs currently available to treat diabetes cures or prevents diabetic kidney disease. The use of the nonpharmacological approaches to diabetes to improve diabetes control, and to prevent or delay its deterioration, seems to be more effective than pharmacological treatment of diabetes to prevent diabetic kidney disease." - Anonymous Online Contributor
"While many of the treatments used in MS have positive effects on the general health of patients, there are certain treatment options which may lead to problems or complications. The goal should always be the improvement of the overall quality of life of patients." - Anonymous Online Contributor
"Diabetes represents an autoimmunological disease involving diabetes mellitus, whose autoantibodies target and attack components of the diabetic organ. The pathogenic mechanisms are quite complex and remain under investigation. These are multiple and are caused by T cells that use CD8 cells as antigen targets. These autoimmune processes may include defects in lymphatic transport, impaired clearance of the amyloid beta peptide, impaired regeneration of pancreatic islets, and aberrant activation and function of these cells by thymic stromal lymphopoietin (TSLP), an inflammatory cytokine, or by other factors associated with diabetes." - Anonymous Online Contributor
"An estimated 39 million people are diagnosed with type 1 or type 2 diabetes in the U.S. every year. This estimate is consistent with findings from previous studies." - Anonymous Online Contributor
"The cause of diabetes is unknown, but there is a strong genetic component to type 1 diabetes, with the risk increasing with age. Diabetes can be triggered by lifestyle factors and genetics.\n" - Anonymous Online Contributor
"The findings do not allow a recommendation for which patients are suitable candidates for a clinical trial program related to diabetes for the purposes of achieving a new therapeutic target of diabetes." - Anonymous Online Contributor
"Patients who choose not to pursue stem cell educator counseling may be at higher risk for poor glucose control after the 2-year visit. The authors recommend that patients contemplating such therapies consider the benefits before the burden of high-cost, frequent visits required for the treatment." - Anonymous Online Contributor
"Autoimmune diabetes is the most common form of diabetes, representing 40% of all diabetes cases. Diabetes was initially believed to be a secondary outcome, which might relate to autoimmunity as an initial cause." - Anonymous Online Contributor
"Our evidence suggests that the disease may be influenced by genetic influences operating in a manner similar to type 1 diabetes and scleroderma. A high-resolution genomic strategy will elucidate the exact genetic basis of the disease." - Anonymous Online Contributor
"The risk of adverse events and lack of clinical benefit do not justify the cost, risk and the adverse psychological effects of HSC educator therapy for people with IBD; however, these data support the theory that this safe procedure may be useful in patients with other conditions, particularly IBD and systemic autoimmune diseases." - Anonymous Online Contributor
"A non-commercial program of stem cell educator training on lifestyle for diabetes and autoimmune diabetes has positive effects on psychological distress, HbA1c and QoL scores." - Anonymous Online Contributor